Wolverine Trading’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.66M | Buy |
26,500
+4,300
| +19% | +$300K | ﹤0.01% | 2367 |
|
|
2025
Q2 | $1.69M | Sell |
22,200
-23,000
| -51% | -$1.81M | ﹤0.01% | 1830 |
|
|
2025
Q1 | $3.93M | Buy |
45,200
+29,900
| +195% | +$2.82M | ﹤0.01% | 1120 |
|
|
2024
Q4 | $1.39M | Sell |
15,300
-8,300
| -35% | -$851K | ﹤0.01% | 2323 |
|
|
2024
Q3 | $2.65M | Buy |
23,600
+300
| +1% | +$30K | ﹤0.01% | 1492 |
|
|
2024
Q2 | $2.28M | Buy |
23,300
+6,500
| +39% | +$645K | ﹤0.01% | 1512 |
|
|
2024
Q1 | $1.68M | Buy |
16,800
+4,000
| +31% | +$352K | ﹤0.01% | 1744 |
|
|
2023
Q4 | $1.15M | Sell |
12,800
-7,600
| -37% | -$606K | ﹤0.01% | 2187 |
|
|
2023
Q3 | $1.57M | Sell |
20,400
-2,700
| -12% | -$224K | ﹤0.01% | 1763 |
|
|
2023
Q2 | $1.92M | Buy |
23,100
+15,500
| +204% | +$1.26M | ﹤0.01% | 1498 |
|
|
2023
Q1 | $630K | Sell |
7,600
-16,100
| -68% | -$1.38M | ﹤0.01% | 2289 |
|
|
2022
Q4 | $1.93M | Buy |
23,700
+12,400
| +110% | +$999K | ﹤0.01% | 1408 |
|
|
2022
Q3 | $800K | Sell |
11,300
-1,600
| -12% | -$144K | ﹤0.01% | 2163 |
|
|
2022
Q2 | $1.18M | Sell |
12,900
-10,800
| -46% | -$1.12M | ﹤0.01% | 1786 |
|
|
2022
Q1 | $2.71M | Buy |
23,700
+5,800
| +32% | +$680K | ﹤0.01% | 1497 |
|
|
2021
Q4 | $2.14M | Sell |
17,900
-11,900
| -40% | -$1.32M | ﹤0.01% | 1822 |
|
|
2021
Q3 | $3.1M | Buy |
29,800
+6,700
| +29% | +$739K | ﹤0.01% | 1691 |
|
|
2021
Q2 | $2.68M | Buy |
23,100
+13,700
| +146% | +$1.64M | ﹤0.01% | 1689 |
|
|
2021
Q1 | $1.05M | Buy |
+9,400
| New | +$1.02M | ﹤0.01% | 2696 |
|
|
2020
Q3 | – | Sell |
-29,700
| Closed | -$2.06M | – | 4667 |
|
|
2020
Q2 | $2.06M | Sell |
29,700
-10,500
| -26% | -$662K | 0.01% | 1395 |
|
|
2020
Q1 | $1.91M | Buy |
40,200
+15,300
| +61% | +$983K | 0.01% | 1380 |
|
|
2019
Q4 | $1.95M | Sell |
24,900
-6,900
| -22% | -$531K | ﹤0.01% | 1855 |
|
|
2019
Q3 | $2.33M | Buy |
31,800
+10,700
| +51% | +$768K | 0.01% | 1330 |
|
|
2019
Q2 | $1.64M | Sell |
21,100
-7,800
| -27% | -$593K | ﹤0.01% | 1647 |
|
|
2019
Q1 | $2.19M | Buy |
+28,900
| New | +$2.3M | 0.01% | 1467 |
|
|
2018
Q4 | – | Sell |
-39,600
| Closed | -$3.79M | – | 4640 |
|
|
2018
Q3 | $3.79M | Sell |
39,600
-24,600
| -38% | -$2.44M | 0.01% | 1162 |
|
|
2018
Q2 | $6.78M | Hold |
64,200
| – | – | 0.02% | 682 |
|
|
2018
Q1 | $6.78M | Buy |
64,200
+12,200
| +23% | +$1.23M | 0.02% | 682 |
|
|
2017
Q4 | $4.82M | Sell |
52,000
-6,300
| -11% | -$572K | 0.02% | 885 |
|
|
2017
Q3 | $5.28M | Sell |
58,300
-2,500
| -4% | -$213K | 0.02% | 729 |
|
|
2017
Q2 | $5.07M | Buy |
60,800
+9,800
| +19% | +$790K | 0.02% | 661 |
|
|
2017
Q1 | $4.13M | Sell |
51,000
-11,200
| -18% | -$881K | 0.02% | 735 |
|
|
2016
Q4 | $4.68M | Buy |
62,200
+3,800
| +7% | +$274K | 0.02% | 771 |
|
|
2016
Q3 | $3.88M | Sell |
58,400
-37,900
| -39% | -$2.54M | 0.02% | 895 |
|
|
2016
Q2 | $6.48M | Buy |
+96,300
| New | +$7.08M | 0.04% | 505 |
|
Other funds holding EMN
Wolverine Trading's EMN Position: Q3 2025 in Review
Wolverine Trading reduced its Eastman Chemical (EMN) stake by 62% in Q3 2025, selling an estimated $876K and leaving 7,612 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #3771.
Wolverine Trading first reported a position in EMN in Q3 2016 and has held it in 17 quarters since. The position peaked at $2.03M in Q4 2016. 662 funds tracked by Wall St. Rank hold EMN as of Q3 2025.
- Wolverine Trading held 7,612 shares of Eastman Chemical worth $477K as of Q3 2025.
- Wolverine Trading sold 12,545 Eastman Chemical shares in Q3 2025, an estimated $876K.
- Eastman Chemical made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3771 holding.
- Wolverine Trading first reported a position in Eastman Chemical in Q3 2016 and has held it in 17 quarters since.
- Wolverine Trading's Eastman Chemical position peaked at $2.03M in Q4 2016.
- 662 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.